4-nitrobenzylthioinosine has been researched along with Atypical Mycobacterial Infection, Disseminated in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Aragaw, WW; Barros-Aguirre, D; Cacho-Izquierdo, M; Dartois, V; Del Río, RG; Dick, T; Ganapathy, US; Gengenbacher, M; Lelièvre, J; Lindman, M; Ortega, F; Zimmerman, MD | 1 |
1 other study(ies) available for 4-nitrobenzylthioinosine and Atypical Mycobacterial Infection, Disseminated
Article | Year |
---|---|
A Mycobacterium tuberculosis NBTI DNA Gyrase Inhibitor Is Active against Mycobacterium abscessus.
Topics: Animals; Mice; Microbial Sensitivity Tests; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Mycobacterium tuberculosis; Nontuberculous Mycobacteria; Thioinosine; Topoisomerase II Inhibitors | 2021 |